Royal Wolverhampton signs three-year deal with Medopad
The British technology company’s solution will be introduced in a number of areas of the trust including cardiology, hypertension and diabetes.
Back to Top
The British technology company’s solution will be introduced in a number of areas of the trust including cardiology, hypertension and diabetes.
The aim of the evaluation was to use the feedback to improve patient experience of the app and to plan support for GP practices.
The eRehabilitation Prescription is part of a 3-step discharge process, helping trauma patients leaving Southmead Hospital to better manage their aftercare
The funding boost, through the government’s Digital Health Technology Catalyst, aims to accelerate the development of digital health innovation.
NHS Greater Glasgow and Clyde believes the trial will result in fewer hospital visits for COPD patients – which costs about £6,000 per admission.
Leanne Summers, digital strategy delivery lead for NHSE, also said that of the 2,650 only 270 (10%) had actually booked appointments through the app.